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1 Abstract
2 Objectives
3 In the context of tightening fiscal budgets and increased commissioning responsibility, local decision 
4 makers across the UK healthcare sector have found themselves in charge of the implementation and 
5 evaluation of a greater range of healthcare interventions and services.  However, there is often little 
6 experience, guidance, or funding available at a local level to ensure robust evaluations are 
7 conducted.  In this paper, we evaluate the possible scenarios that could occur when seeking to 
8 conduct a quantitative evaluation of a new intervention, specifically with regards to availability of 
9 evidence.   
10 Design
11 We outline the full set of possible data scenarios that could occur if the decision maker seeks to 
12 explore the impact of the launch of a new intervention on some relevant quantifiable outcome.  In 
13 each case we consider the implicit assumptions associated with conducting an evaluation, exploring 
14 possible situations where such scenarios may occur.  We go on to apply the scenarios to a simulated 
15 dataset to explore how each scenario can result in different conclusions as to the effectiveness of 
16 the new intervention. 
17 Results
18 We demonstrate that, across the full set of scenarios, differences in the scale of the estimated 
19 effectiveness of a new intervention and even the direction of effect, are possible given different data 
20 availability and analytical approaches. 
21 Conclusions
22 When conducting quantitative evaluations of new interventions, the availability of data on the 
23 outcome of interest and the analytical approach can have profound effects on the conclusions of the 
24 evaluation.  While it will not always be possible to obtain a complete set of data and conduct 
25 extensive analysis, it is vital to understand the implications of the data used and consider the implicit 
26 assumptions made through its use.  
27
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1 Strengths and limitations of this study
2  Highlights the risks of partial analysis of time series data used to evaluate the impact of a 
3 service
4  Presents the assumptions implicitly made through the differential use of data to inform 
5 quantitative evaluation in a range of scenarios 
6  Demonstrates that even a well-designed analysis is constrained by the available data
7  Provides guidance aimed at local decision makers, who are typically overlooked in the 
8 published methodological guidance 
9  The use of simulated data allows for a clear demonstration of the scenarios but risks 
10 oversimplifying the nature of “real world” data
11
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1 Introduction
2 Clinical Commissioning Groups (CCGs), Local Authorities, and other local decision makers are under 
3 increasing pressure to demonstrate the value of any newly commissioned activities given tightening 
4 fiscal budgets.  While the Health and Social Care Act of 2012[1] was instrumental in allowing local 
5 decision makers to be responsive to the health needs of the population they serve, it provided little 
6 guidance on how to do so in an effective and cost-effective manner.  As a result, local decision 
7 makers have found themselves caught between two worlds, neither being served by national 
8 evidence generation due to the decentralisation of funding, nor with the ability, finance, or structure 
9 to generate robust evidence, such as randomised trials.
10 Whilst collaborations between the Local Government Association, Department of Health, NHS 
11 England, and others have led to a number of guides for good evaluation and evidence generation, [2-
12 4] these have had a broad focus on the theory of good research, rather than offering practical advice 
13 for analyses.  
14 While in some cases, such as the Vanguard projects, [4] funding has been ring fenced for evaluation, 
15 it is more common that the decision to conduct a service evaluation by local decision makers comes 
16 at the detriment of the service provision itself.  As a consequence, any evaluation may be limited in 
17 scope, and the ability to fund sufficiently robust data collection severely compromised.  While there 
18 are inevitably risks of funding services based on inadequate evidence, as we will go on to 
19 demonstrate, there is little logic in funding sophisticated studies that threaten provision of the 
20 service itself.  
21 It has been the experience of these authors (GR is the University of York representative on York 
22 Teaching Hospital’s Council of Governors; GR and LB are members of the Vale of York CCG’s 
23 Research Group; and GR, LB and SH have experience in evaluating a number of local interventions 
24 including the Harrogate and District CCG’s Vanguard programme, a Core-24 hour mental health 
25 liaison service, and Tier 3 weight loss services) that these factors have resulted in either no 
26 quantitative evaluation of new service provision or evaluations that are based on limited 
27 interpretations of outcome measures and incomplete data collection.  This is despite the move 
28 towards monitoring of services, both for quality and financial reasons, and falls in the cost of data 
29 generation, which have meant its collection and use is no longer an insurmountable barrier to 
30 evaluation.  
31 In this paper, we explore a range of different scenarios faced by a local decision maker depending on 
32 the availability of data and analytical approach taken.  We go on to use a stylised case study to 
33 explore the implications of each scenario on the estimated impact of the intervention and the likely 
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1 conclusions.  We focus on a quantitative evaluation but highlight the importance of a mixed-method 
2 approach in achieving a robust evaluation. 
3 We take as a starting point a decision maker who is seeking to evaluate a new intervention, where 
4 intervention is used to describe any new or change in service, care pathway or treatment.  They 
5 possess time series data on an outcome of interest over a series of time-points, which is 
6 hypothesised to be impacted by the new intervention.  These data may be at an aggregated level 
7 (e.g. local population) or data for individuals (e.g. patients or households).  Such a generalised 
8 situation is common, with the decision maker being anything from CCGs, Local Authorities, to mental 
9 health providers.  While the possible set of outcomes of interest is wide, the need to generalise 
10 findings often results in focus being on broad process outcomes such as non-elective attendances, 
11 and length of stay, which are easily benchmarked.  Such an analysis is expected to play a role in a 
12 decision making process informed by a number of other quantitative and qualitative considerations. 
13
14 The Different Scenarios
15 In this section, we consider the full set of data scenarios and analytical approaches that may occur 
16 when seeking to evaluate the impact of the launch of a new intervention on a single outcome of 
17 interest.  We explore the range of implicit assumptions that are made for each of the scenarios, and 
18 possible examples of how each may occur.  The different cases are characterised as six overarching 
19 scenarios.  It is the experience of these authors that it is most common for evaluation of an 
20 intervention to be done retrospectively or towards the end of a project, primarily due to a lack of 
21 evaluative experience and funding to embed evaluation from an early stage; however, there is a lack 
22 of reviews of the methodology applied by local decision makers in such setting.
23
24 Scenario 1 – follow-up data but no pre-launch data for the intervention area
25 In its simplest form an evaluation may consist of only data collected after the launch of an 
26 intervention with no historical evidence, for example if the intervention was unplanned and data 
27 could not be collected retrospectively, such as a piece of hospital infrastructure being replaced.  
28 Such an analysis can therefore only comment on the trajectory of the data over the intervention 
29 period as there is no knowledge of the counterfactual (what would have happened had the 
30 intervention not occurred), and no data on which to base any estimation.  If any estimation of the 
31 total impact of the intervention is required, assumptions or external evidence would be required to 
32 inform the counterfactual. 
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1
2 Scenario 2 – follow-up data and a single pre-launch data point for the 
3 intervention area
4 Secondly, we consider a situation where the decision maker has only historic data for the final 
5 period before the launch of an intervention.  Such a situation may occur when the decision to 
6 conduct an evaluation occurs only a short time before the launch and data cannot be collected 
7 retrospectively.  Depending on the aggregation and availability of data two sub-scenarios are 
8 available:
9 A. Data are only available for the last period before launch and a single time point of the post-
10 launch time series, a simple before and after statement is possible. In all cases, some implicit 
11 or explicit statement is beneficial regarding the generalisability of the observed data and 
12 trends in the data over the intervening time-period.  Such as case would occur if data were 
13 only available at set time points and only informative of a short time period, for example 
14 annually occurring surveys or audits. 
15 B. Data are available for the last period before launch and all post-intervention time points, 
16 allowing an average change over the period from the first time point to be calculated with 
17 some additional knowledge of how the data changed over the period.  This might occur if 
18 repeated data collection is possible prospectively, such as the collection of electronic patient 
19 data once relevant patients have been identified and consented.   
20 Given the limited pre-launch data available in this scenario, we must assume that, had the 
21 intervention not been launched, the outcome would have stayed at the same level as in the last time 
22 point before launch.  While this assumption is inevitable if no other data are available, it risks being 
23 misleading if there is some underlying trend in the outcome, or if it is subject to natural variation 
24 from one time point to the next.  
25
26 Scenario 3 – data are available covering the full pre and post-launch period for 
27 the intervention area
28 To overcome the limitations of scenario 2, historic data in the intervention area can be used to 
29 inform the baseline value and any underlying trends in the outcome over time by relaxing the 
30 assumption that outcome data would have remained static.  As with scenario 2, alternative 
31 aggregation of the historic data can result in different implications:
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7
1 A. Both pre- and post-launch, may only be available as average values aggregated over a long 
2 period, for example if the data access is limited to annual audit figures that cover the entire 
3 pre-launch period.  This scenario implies that no consideration of the disaggregated trends 
4 are possible.  
5 B. Extensive disaggregated data are available both before and after the launch.  This allows for 
6 the direct comparison of each post-launch time-period with some matched period in the 
7 pre-intervention data, for example comparing January in one year with January in the next.  
8 The matching is used to conduct the analysis at a more disaggregated level, as well as 
9 adjusting for other factors such as seasonality and budgetary cycles.  While the average 
10 estimate of the impact of the intervention launch will be the same as part A, we now have 
11 the ability to investigate the change in trend over the time-period. Such a case would occur 
12 either when an evaluation and data collection was started some time before the 
13 intervention launch, or when data on the outcome is readily available retrospectively.  For 
14 example, if the evaluation is concerned with emergency department attendances over time, 
15 historic data can typically be retrospectively collected.  
16
17 Scenario 4 – data are available on a control area post-launch as well as the 
18 intervention area data
19 Scenarios 1-3 describe when data are only available for the area covered by the intervention.  
20 However, data are often available for comparator areas as the informative outcome is often 
21 routinely collected and available across multiple areas, through systems such as Hospital Episode 
22 Statistics (HES), or collection can be prospectively arranged.  Such comparator areas can be local, 
23 regional, national, or a synthetic comparator created by combining a number of areas.  To be an 
24 informative comparator the area must represent a good match to the intervention area in all 
25 relevant characteristics and not be impacted by the launch of the new service being evaluated.[5]  
26 The goodness of the match can be determined qualitatively or quantitatively by comparing the 
27 known features of the two areas. 
28 The most common use of such control data is to directly compare the post intervention outcomes in 
29 the two areas, using the same approach as scenario 3, but with the contemporary control data are 
30 used instead of the historic intervention area data.  As before, there are two categories:
31 A. Only aggregate data are available post intervention launch for the two areas.  As in previous 
32 scenarios, an example of this would be analyses based on audit data alone but now across 
33 multiple areas. 
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8
1 B. Disaggregated data are available post intervention, allowing a disaggregated matched 
2 comparison can be made which again, results in the same total estimated impact as part A 
3 but gives us an understanding of the respective trends.  This situation would occur where an 
4 intervention is only launched in one part of a larger geographic area or patient group where 
5 the decision makers has access to the data of the full set prospectively, for example one GP 
6 practice in a CCG area. 
7 Under this scenario, comparator area data are used either instead of, or due to a lack of, historic 
8 evidence as used in scenario 3.  Using simple analytical techniques there is no way to incorporate 
9 both, which we will explore in scenario 6.  There is no definitive rule for whether historic or 
10 contemporary comparator evidence is more appropriate, it is situation dependent.  For example, if 
11 the intervention of interest was not the only change at the point of launch of the intervention, the 
12 control area data would likely be most appropriate if the second new service was launched in both 
13 areas, but not if it were only in the control area.  A number of other factors must be considered, for 
14 example, what if comparator data are available but is not a good match, how does one define a 
15 suitable match, and what if there are multiple comparators potentially telling different stories?
16
17 Scenario 5 – all pre and post-launch data are available for the intervention 
18 area
19 In this scenario and scenario 6 we explore the addition of more advanced analytical approaches to 
20 the analysis of the data, specifically the use of interrupted time series (ITS) or ‘segmented 
21 regression’ analysis.  This approach has been well presented in the literature,[6-8] but in brief, the 
22 method considers the trend in an outcome of interest over time, segmenting it into the period 
23 before the intervention was launched, and after it.  The example of using pre- and post-launch data 
24 for the intervention area is shown in the explanatory Error! Reference source not found., where the 
25 pre-launch data are used to infer a post-launch counterfactual case, with the nature of the change in 
26 the outcome define a-priori.  Using the framework described by Bernal[8] it is possible to define the 
27 regression model using the equation detailed below, where Y is the aggregated outcome, β 
28 represents the relevant coefficients, T the time since the start of the study, t the specific time-point, 
29 X is a dummy variable indicating when the new intervention is active, and ε the error term.
30
31 𝑌𝑡 =  𝛽0 +  𝛽1𝑇𝑡 +  𝛽2𝑋𝑡 +  𝛽3𝑋𝑡𝑇𝑡 +  𝜀𝑡
32
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9
1 The application of such a regression model allows for the formal estimation of whether any change 
2 in the outcome of interest is statistically significant under a frequentist framework, and for any 
3 change to be quantified by estimating the area between the two regression lines, shown in Error! 
4 Reference source not found., over the analysis period.
5 The use of such method requires time series data both before and after the launch in the 
6 intervention area, as in scenario 3B.
7 [Figure 1 here]
8 Scenario 6 - data are available on both control and intervention areas pre- and 
9 post-launch 
10 We demonstrated in scenario 4 that the addition of control area data typically implied the exclusion 
11 of historic intervention area data in informing the counterfactual.  Using ITS methodology it is 
12 possible to formally incorporate comparator data, potentially from multiple areas or a synthetic 
13 area, alongside the full set of intervention area data.  The method uses the pre-intervention data to 
14 formally test whether the comparator areas can be considered a good match.  If so, the post-launch 
15 comparator data are then used to infer the post-launch counterfactual of the intervention area.  
16 Therefore, this approach assumes that the control area is indicative of what would have happened 
17 to the outcome in the intervention area had the launch not occurred, much as we assumed in 
18 scenario 4 but with a formal assessment of the trend and reliability of the comparator.  The equation 
19 detailed in scenario 5 can be extended by incorporating a Z term as a dummy for assignment to the 
20 treatment or control population, as detailed by Linden[7]:
21
22 𝑌𝑡 =  𝛽0 +  𝛽1𝑇𝑡 +  𝛽2𝑋𝑡 +  𝛽3𝑋𝑡𝑇𝑡 + 𝛽4𝑍 +  𝛽5𝑍𝑇𝑡 +  𝛽6𝑍𝑋𝑡 +  𝛽7𝑍𝑋𝑡𝑇𝑡 +  𝜀𝑡
23
24 Comparing the Scenarios 
25 Each of the scenarios outlined above is characterised by a set of core assumptions, made implicitly 
26 or explicitly, if used to evaluate the impact of a new intervention on some outcome of interest.  
27 Similarly, the variability in the ease of implementation, and data and analytical requirements of each 
28 scenario implies a range of pros and cons associated with each.  These are presented in Table 1, 
29 which highlights that the more analytically simple and data light the scenario the stronger the core 
30 assumption required about the nature of the interaction with the outcome and time trends in the 
31 data.
32
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1
2 Table 1: Summary of the different analytical methods
Method Core assumptions Pros Cons
Scenario 1, only data 
after launch in the 
intervention area
Only the change in the data after 
the launch is relevant to the 
evaluation.
Requires little data or technical 
knowledge.
Unable to comment on the 
change in the outcome of 
interest because of the 
intervention, only its trend after 
launch.
Scenario 2A, first and last 
time point of intervention 
period
The two data points are fully 
indicative of the change.
Requires little data or technical 
knowledge.
Highly dependent on small array 
of data.
Risks loss of important details of 
data, intervention effect, or 
trends.
Scenario 2B, 
disaggregated change 
from starting period
Last pre-intervention period fully 
represents the counterfactual.
Only requires one pre-
intervention data point.
Analytically simple. 
Highly dependent on small array 
of control data.
No consideration of trend in 
counterfactual.
Scenario 3A, simple 
average of historic 
intervention area data
Simple averaging of before and 
after data incorporates all 
factors, there is no value in an 
assessment of the trends.
Only requires small amount of 
pre and post data.
Analytically simple.
Fails to explore trends in data. 
Scenario 3B, matched pre 
and post intervention
There is a repeating periodic 
fluctuation, e.g. seasonality, that 
impacts the outcome of interest 
and the trend over time is 
informative.
Simple means of adjusting for 
periodic fluctuations.
Result varies given matching 
approach.
Blunt means of adjusting for 
periodic fluctuations that can 
result in incorrect estimates.
Scenario 4A, comparison 
of averages post 
intervention in control 
and intervention areas
The selected control area fully 
represents the counterfactual of 
the intervention area.
Allows for use of control area 
data.
Only requires post-launch data.
Fails to explore trends in data. 
Makes no use of historic data.
Difficult to determine if the 
control area represents a 
reasonable comparator. 
Scenario 4B, matched 
post intervention control 
and intervention area
The selected control area fully 
represents the counterfactual of 
the intervention area and the 
trend over time is informative.
Allows for use of control area 
data.
Explores trends in data without 
having to define a cycle length.
Only requires post-launch data.
Makes no use of historic data.
Difficult to determine if the 
control area represents a 
reasonable comparator.
Scenario 5, ITS analysis of 
intervention area
Regression of pre-intervention 
data fully represents post-
intervention counterfactual and 
the trend over time is 
informative.
Allows for use of historic control 
data.
Explores the trends.
Reliant on historic intervention 
area data being predictive of 
counterfactual.
Scenario 6, ITS analysis of 
control and intervention 
area
Control area fully represents 
counterfactual of intervention 
area but the match can be tested 
by exploring the pre-intervention 
data. The trend over time is 
informative.
Allows for use of control area 
and exploration as to the 
closeness of the control and 
intervention areas. 
Assumption that the control area 
continues to represent a good 
match after the intervention 
period.
3 Case study
4 To explore the practical implications of the different scenarios, and demonstrate the potential for 
5 varied conclusions, we have created a case study to which each is applied.  To inform the case study 
6 a time series dataset of an outcome unit of interest (e.g. bed days, hospital admissions, or indicators 
7 of quality and care outcome) has been simulated.  The data values and number of time points has 
8 been selected to best inform the characteristics of each of the scenarios described in Table 1 while 
9 representing the uncertain nature of real world data relevant to this setting.  Please see the 
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1 supplementary files (“Fabricated data scenarios.xlsm", "Paper analysis.do" and "Fabricated 
2 data.dta“) for additional detail on the data and analyses conducted. 
3 This data relates to two distinct groups (intervention and control) and a maximum of 30 
4 observations are available over some defined time period at regular intervals (e.g. every week, 
5 month, or year).  The data are structured such that in both areas the outcome was increasing for the 
6 first 15 observations at a rate of 4/3 per time period from a mean value of 20 units at time 1, after 
7 which point the intervention is implemented in the intervention area but not the control.  From time 
8 point 15 onwards in the intervention area the outcome decreases at the same rate of 4/3 units per 
9 period, while in the control area the outcome levels off, assumed to be due to factors unrelated to 
10 the intervention.  All time points are subject to some level of variation to mimic what is observed in 
11 real world data, simulated using a normal distribution (mean 45 and standard deviation 5).  We 
12 assume that after launch (t=15) the new service becomes fully operational, with no run in period.  
13 The last time point in the intervention area (t=30) was set as an extreme outlier (estimated as 
14 occurring with a probability of 0.99999 on the simulated distribution) to explore its impact on the 
15 results, for example if an exogenous factor affected the intervention such as failure of a key piece of 
16 machinery.  Error! Reference source not found. shows the fabricated data in full, with each data 
17 point representing the time period before, such that data point 1 being the total outcome over times 
18 0 to 1.  
19  [Figure 2 here]
20 Using the informative structure of the simulated case study it is possible to estimate two possible 
21 underlying effect values.  If the control area is the best indicator of the counterfactual the 
22 intervention resulted in a reduction of 151 units over the period, if the historic intervention area is 
23 best, a reduction of 324 units.  While these values can help us to understand the results of the 
24 different scenarios they must be interpreted with caution; as while they inform the underlying trend 
25 used to simulate the data the case study time points were sampled independently. 
26 In the next part we explore what the data availability would look like under each of the scenarios 
27 outlined in the previous section, estimating what the impact and conclusions would be regarding the 
28 effectiveness of the intervention.  As outlined earlier, in many of the cases only a limited set of the 
29 data are available, indeed it is only scenarios 4 and 6 where the full dataset is available to the 
30 decision maker.  Error! Reference source not found. provides an overview of the data availability 
31 across all of the scenarios.
32
33 [Figure 3 here]
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1
2
3
4
5
6
7 Table 2 gives an overview of the results of the different possible scenarios and possible 
8 interpretations.  
9 Table 2: Summary of the different scenarios results
Scenario Possible interpretation of the result Estimated change1 
Scenario 1, only data after 
launch in the intervention 
area
The outcome of interest appears to have decreased over 
the post-launch time-period
not possible to 
estimate a change in 
the outcome
Scenario 2A, first and last time 
point of intervention period
There appears to have been an increase in the outcome 
from the pre-launch to post-launch period.  
Extrapolating the observed values over the entire 15 
months of intervention suggests that the new 
intervention had increased the outcome by 37.6 units 
((44.9-42.4)x15)
37.6
Scenario 2B, disaggregated 
change from starting period
The outcome of interest appears to have decreased over 
time from the pre-launch time-period, with an estimated 
change of -120.1 units over the period ((34.4-42.4)x15)
-120.1
Scenario 3A, simple average of 
historic intervention area data
There appears to have been little change from the pre- 
to post-launch periods in the outcome, with the average 
value going from 35.1 to 35.4
((35.4-35.1)x15)
4.9
Scenario 3B, matched pre and 
post intervention
There appears to have been little change from the pre- 
to post-launch periods in the outcome, with the average 
value going from 35.1 to 35.4. However, it appears from 
the data that there was an increasing trend in the 
outcome before the intervention and a decreasing trend 
afterwards
((35.4-35.1)x15)
4.9
Scenario 4A, comparison of 
averages post intervention in 
control and intervention areas
Compared to the control area the intervention area had 
a lower average level of the outcome after the launch of 
the intervention
-146.0
Scenario 4B, matched  post 
intervention control and 
intervention area
Compared to the control area the intervention area had 
a lower average level of the outcome after the launch of 
the intervention.  The control area appeared to have a 
flat trend in the outcome over the post-launch period 
compared to a decreasing trend in the intervention area
((35.4-45.1)x15)
-146.0
Scenario 5, ITS analysis of 
intervention area
Compared to the pre-launch intervention area the post-
launch saw a decrease in the trend over time in the 
outcome, from positive to negative, which was 
statistically significant
See the Supplementary Appendix for regression
-258.8
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13
Scenario 6, ITS analysis of 
control and intervention area
Both control and intervention areas saw a shallowing of 
the trend over time.  The intervention area saw a greater 
decrease in the trend, being negative compared to the 
relatively flat trend in the control.  This different was 
statistically significant. The control area was found to be 
a match to the intervention area in the pre-launch 
period (the regressions lines are aligned), See the 
Supplementary Appendix for regression
-146.0
1 1negative values indicate that the new service reduced the outcome
2 Error! Reference source not found. and Table 2 demonstrate the large potential for variation in the 
3 estimated impact of the intervention, and the overall conclusions that could be drawn given the 
4 different scenarios.  Estimations of the change in the outcome vary from predicting the intervention 
5 increased the outcome by 37.6 units over the post-intervention period (scenario 2A), to decreasing it 
6 by 258.8 (scenario 5).  Similarly the interpretations differ in their ability to identify the trends in the 
7 different areas and time periods, as well as the overall impact of the intervention.  
8 In the case study presented here, with full access to the data and knowledge of the underlying 
9 trends in the simulated data, it is clear that several of these scenarios result is a very incorrect 
10 conclusion.  However, the appropriat ness of the scenarios and accuracy of their conclusions 
11 compared to any ‘true’ effects are clearly much harder to determine in the real world.
12
13 Discussion
14 In this paper we have explored a range of possible scenarios and analytical approaches available to a 
15 decision maker when evaluating the impact of a new intervention on an outcome of interest, 
16 highlighting the implicit assumptions made in each.  Through our simulated case study we have 
17 demonstrated how these scenarios can yield very different estimates of effectiveness.  
18 Comparison of the methods explored here suggests that it is intuitively appealing to conclude that 
19 the approach outlined in scenario 6, using the ITS methodology including the control area 
20 comparison, is the most accurate as it incorporates the most complete set of data whilst taking the 
21 most complete approach to statistical analysis.  However, the most appropriate methodology may 
22 be driven by other factors, primarily the availability of informative data and the validity of the core 
23 assumptions detailed in Table 1. 
24 Furthermore, the use of ITS analysis (scenarios 5 and 6) is not without assumptions, primarily 
25 relating to the suitability of the historic and control area data to inform the counterfactual, and the 
26 functional form of the trends modelled.  It also requires a significant level of data and analytical 
27 ability to implement.  However, the inability to observe exactly what would happen in the 
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14
1 intervention area without the new service, necessitates such assumptions in order to estimate the 
2 impact of its launch.  Fears about the robustness of such assumptions are likely to be best addressed 
3 by the identification of additional relevant evidence to either adjust the existing data or inform a 
4 new comparator.  For example, methods are available to overcome concerns over additional service 
5 changes in the time period covered by the data,[7] to incorporate multiple control areas,[7] and to 
6 conduct a more rigorous selection of control area through matching.[9]
7 As with all such analyses, the ITS methodology can be extended to consider the significance of the 
8 findings beyond pure chance.  This can be achieved through a frequentist framework, considering 
9 the statistical significance of the regression estimates, as discussed in Linden et al.,[7] or through a 
10 Bayesian framework.[10]  Such considerations should play an important role in the decision making 
11 process, as a single estimate of the impact on an intervention can be misleading. Specifically, it fails 
12 to take account of the uncertainty, of the informative data or the consequences of making an 
13 incorrect funding decision.  However, it is important to reflect that even if there is substantial 
14 uncertainty it is the expected  impact of the intervention that should be most informative to the 
15 commissioning decision, rather than the significance of the impact, [11]. 
16 An intrinsic element to any analyses explored in this paper is an understanding of the data under 
17 interrogation: the application of robust methods is only helpful if the data being used is consistent 
18 and relevant to the question being addressed.  Prior to any analysis it is important to understand the 
19 data, answering questions such as: how was it generated; is an estimate of the rate of an event more 
20 relevant than its frequency; is it consistent over the time period of interest; what is the route of 
21 causality between the intervention of interest and the data; and when plotted do there appear to be 
22 any unexplainable outliers? 
23 Analyses such as those presented here are most robust when combined with qualitative 
24 methodologies through a mixed-method approach, with the qualitative findings ideally facilitating a 
25 more detailed understanding of the trends seen in the data and informing the suitability of the 
26 different counterfactual scenarios.  Such a mixed-methods approach may extend the quantitative 
27 incorporate health economic considerations, such that the generalisable cost-effectiveness of the 
28 intervention is considered. 
29 Furthermore, the use of robust methodologies, such as ITS analysis, does not replace the need for 
30 the robust selection of outcomes and data collection, as any analysis can only be as robust as the 
31 data that informs it.  Failure to prospectively design the launch of an intervention and associated 
32 evaluation to ensure  , the required level of data collection, and sufficient consideration of a 
33 contemporaneous control, will likely lead to an erroneous result whatever evaluative method is 
34 used.  
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1 Figure legends and captions
2 Figure 1: ITS analytical method
3 Figure 2: Fabricated time series data
4 Figure 3: Data availability across the different scenarios of the case study
5
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Figure 1: ITS analytical method 
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Figure 2: Fabricated time series data 
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Figure 3: Data availability across the different scenarios of the case study 
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Figure 3: Data availability across the different scenarios of the case study 
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Supplementary Appendix: Regression output for ITS analysis (scenarios 5 and 6) 
This appendix reports the regression outputs for the ITS analysis presented in scenarios 5 and 6 using 
the ITSA program in Stata. 
Regression output for scenario 5 
 
Outcome 
Coef. 
Newey-West 
Std. Err. 
t P>t 
[95% 
Conf. 
Interval] 
β1 1.172109 0.2951369 3.97 0.001 0.565446 1.778772 
β2 -2.93635 4.039829 -0.73 0.474 -11.2403 5.367642 
β3 -2.04554 0.6483852 -3.15 0.004 -3.37832 -0.71276 
β0 26.88192 2.872154 9.36 0 20.97813 32.78572 
Treated 
(β1[_t]+β3[_x_t16]) 
-0.8734 0.5773 -1.5129 0.1424 -2.0601 0.3133 
 
 
 
Regression output for scenario 6 
outcome 
Coef. 
Newey-West 
Std. Err. 
t P>t [95% Conf. Interval] 
β1 1.128589 0.2891484 3.9 0 0.548371 1.708808 
β4 -0.23341 3.888218 -0.06 0.952 -8.03569 7.568873 
β5 0.04352 0.4131738 0.11 0.917 -0.78557 0.872614 
β2 -0.76556 3.07017 -0.25 0.804 -6.92631 5.395184 
β3 -0.86161 0.3851036 -2.24 0.03 -1.63438 -0.08885 
β6 -2.17078 5.074068 -0.43 0.671 -12.3527 8.011078 
β7 -1.18393 0.7541274 -1.57 0.122 -2.6972 0.32934 
β0 27.11533 2.620871 10.35 0 21.85617 32.37449 
Treated 
(β1[_t]+β5[_z_t] 
+β3[_x_t16] 
+β7[_z_x_t16]) 
-0.8734 0.5773 -1.5129 0.1364 -2.0319 0.285 
Controls 
(β1[_t]+β3[_x_t16]) 
0.267 0.2544 1.0496 0.2988 -0.2434 0.7774 
Difference (β5[_z_t] 
+β7[_z_x_t16]) 
-1.1404 0.6309 -1.8077 0.0764 -2.4063 0.1255 
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2
1 Abstract
2 Objectives
3 In the context of tightening fiscal budgets and increased commissioning responsibility, local decision 
4 makers across the UK healthcare sector have found themselves in charge of the implementation and 
5 evaluation of a greater range of healthcare interventions and services.  However, there is often little 
6 experience, guidance, or funding available at a local level to ensure robust evaluations are 
7 conducted.  In this paper, we evaluate the possible scenarios that could occur when seeking to 
8 conduct a quantitative evaluation of a new intervention, specifically with regards to availability of 
9 evidence.   
10 Design
11 We outline the full set of possible data scenarios that could occur if the decision maker seeks to 
12 explore the impact of the launch of a new intervention on some relevant quantifiable outcome.  In 
13 each case we consider the implicit assumptions associated with conducting an evaluation, exploring 
14 possible situations where such scenarios may occur.  We go on to apply the scenarios to a simulated 
15 dataset to explore how each scenario can result in different conclusions as to the effectiveness of 
16 the new intervention. 
17 Results
18 We demonstrate that, across the full set of scenarios, differences in the scale of the estimated 
19 effectiveness of a new intervention and even the direction of effect, are possible given different data 
20 availability and analytical approaches. 
21 Conclusions
22 When conducting quantitative evaluations of new interventions, the availability of data on the 
23 outcome of interest and the analytical approach can have profound effects on the conclusions of the 
24 evaluation.  While it will not always be possible to obtain a complete set of data and conduct 
25 extensive analysis, it is vital to understand the implications of the data used and consider the implicit 
26 assumptions made through its use.  
27
28
29
30
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3
1 Strengths and limitations of this study
2  Highlights the risks of partial analysis of time series data used to evaluate the impact of a 
3 service
4  Presents the assumptions implicitly made through the differential use of data to inform 
5 quantitative evaluation in a range of scenarios 
6  Demonstrates that even a well-designed analysis is only as good as the 
7 informativeconstrained by the available data
8  Provides guidance aimed at local decision makers, who are typically overlooked in the 
9 published methodological guidance 
10  The use of simulated data allows for a clear demonstration of the scenarios but risks 
11 oversimplifying the nature of “real world” data
12
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4
1 Introduction
2 Clinical Commissioning Groups (CCGs), Local Authorities, and other local decision makers are under 
3 increasing pressure to demonstrate the value of any newly commissioned activities given tightening 
4 fiscal budgets.  While the Health and Social Care Act of 2012[1] was instrumental in allowing local 
5 decision makers to be responsive to the health needs of the population they serve, it provided little 
6 guidance on how to do so in an effective and cost-effective manner.  As a result, local decision 
7 makers have found themselves caught between two worlds, neither being served by national 
8 evidence generation due to the decentralisation of funding, nor with the ability, finance, or structure 
9 to generate robust evidence, such as randomised trials.
10 Whilst collaborations between the Local Government Association, Department of Health, NHS 
11 England, and others have led to a number of guides for good evaluation and evidence generation, [2-
12 4] these have had a broad focus on the theory of good research, rather than offering practical advice 
13 for analyses.  
14 While in some cases, such as the Vanguard projects, [4] funding has been ring fenced for evaluation, 
15 it is more common that the decision to conduct a service evaluation by local decision makers comes 
16 at the detriment of the service provision itself.  As a consequence, any evaluation may be limited in 
17 scope, and the ability to fund sufficiently robust data collection severely compromised.  While there 
18 are inevitably risks of funding services based on inadequate evidence, as we will go on to 
19 demonstrate, there is little logic in funding sophisticated studies that threaten provision of the 
20 service itself.  
21 It has been the experience of these authors (GR is the University of York representative on York 
22 Teaching Hospital’s Council of Governors;, GR and LB are members of the Vale of York CCG’s 
23 Research Group;, and GR, LB and SH have experience in evaluating a number of local interventions 
24 including the Harrogate and District CCG’s Vanguard programme, a Core-24 hour mental health 
25 liaison service, and Tier 3 weight loss services) that these factors have resulted in either no 
26 quantitative evaluation of new service provision or evaluations that are based on limited 
27 interpretations of outcome measures and incomplete data collection.  This is despite the move 
28 towards monitoring of services, both for quality and financial reasons, and falls in the cost of data 
29 generation, which have meant its collection and use is no longer an insurmountable barrier to 
30 evaluation.  
31 In this paper, we explore a range of different scenarios faced by a local decision maker depending on 
32 the availability of data and analytical approach taken.  We go on to use a stylised case study to 
33 explore the implications of each scenario on the estimated impact of the intervention and the likely 
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5
1 conclusions.  We focus on a quantitative evaluation but highlight the importance of a mixed-method 
2 approach in achieving a robust evaluation. 
3 We take as a starting point a decision maker who is seeking to evaluate a new intervention, where 
4 intervention is used to describe any new or change in service, care pathway or treatment.  They 
5 possess time series data on an outcome of interest over a series of time-points, which is 
6 hypothesised to be impacted by the new intervention.  These data may be at an aggregated level 
7 (e.g. local population) or data for individuals (e.g. patients or households).  Such a generalised 
8 situation is common, with the decision maker being anything from CCGs, Local Authorities, to mental 
9 health providers.  While the possible set of outcomes of interest is wide, the need to generalise 
10 findings often results in focus being on broad process outcomes such as non-elective attendances, 
11 and length of stay, which are easily benchmarked.  Such an analysis is expected to play a role in a 
12 decision making process informed by a number of other quantitative and qualitative considerations. 
13
14 The Different Scenarios
15 In this section, we consider the full set of data scenarios and analytical approaches that may occur 
16 when seeking to evaluate the impact of the launch of a new intervention on a single outcome of 
17 interest.  We explore the range of implicit assumptions that are made for each of the scenarios, and 
18 possible examples of how each may occur.  The different cases are characterised as six overarching 
19 scenarios.  While there are few cases where data and analytical capability is not available to conduct 
20 all of the scenarios presented, as is explored alter in this manuscript, some of the more demanding 
21 cases require an element of forethought and buy-in from all stakeholders in order to ensure to 
22 facilitate the most appropriate scenario.  It is the experience of these authors that it is most 
23 common for evaluation of an intervention to be done retrospectively or towards the end of a 
24 project, primarily due to a lack of evaluative experience and funding to embed evaluation from an 
25 early stage;, however, there is a lack of reviews of the methodology applied by local decision makers 
26 in such setting.
27
28 Scenario 1 – follow-up data but no pre-launch data for the intervention area
29 In its simplest form an evaluation may consist of only data collected after the launch of an 
30 intervention with no historical evidence, for example if the intervention was unplanned and data 
31 could not be collected retrospectively, such as a piece of hospital infrastructure being replaced.  
32 Such an analysis can therefore only comment on the trajectory of the data over the intervention 
33 period as there is no knowledge of the counterfactual (what would have happened had the 
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6
1 intervention not occurred), and no data on which to base any estimation.  If any estimation of the 
2 total impact of the intervention is required, assumptions or external evidence would be required to 
3 inform the counterfactual. 
4
5 Scenario 2 – follow-up data and a single pre-launch data point for the 
6 intervention area
7 Secondly, we consider a situation where the decision maker has only historic data for the final 
8 period before the launch of an intervention.  Such a situation may occur when the decision to 
9 conduct an evaluation occurs only a short time before the launch and data cannot be collected 
10 retrospectively.  Depending on the aggregation and availability of data two sub-scenarios are 
11 available:
12 A. Data are only available for the last period before launch and a single time point of the post-
13 launch time series, a simple before and after statement is possible. In all cases, some implicit 
14 or explicit statement is beneficial regarding the generalisability of the observed data and 
15 trends in the data over the intervening time-period.  Such as case would occur if data were 
16 only available at set time points and only informative of a short time period, for example 
17 annually occurring surveys or audits. 
18 B. Data are available for the last period before launch and all post-intervention time points, 
19 allowing an average change over the period from the first time point to be calculated with 
20 some additional knowledge of how the data changed over the period.  This might occur if 
21 repeated data collection is possible prospectively, such as the collection of electronic patient 
22 data once relevant patients have been identified and consented.   
23 Given the limited pre-launch data available in this scenario, we must assume that, had the 
24 intervention not been launched, the outcome would have stayed at the same level as in the last time 
25 point before launch.  While this assumption is inevitable if no other data are available, it risks being 
26 misleading if there is some underlying trend in the outcome, or if it is subject to natural variation 
27 from one time point to the next.  
28
29 Scenario 3 – data are available covering the full pre and post-launch period for 
30 the intervention area
31 To overcome the limitations of scenario 2, historic data in the intervention area can be used to 
32 inform the baseline value and any underlying trends in the outcome over time by relaxing the 
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7
1 assumption that outcome data would have remained static.  As with scenario 2, alternative 
2 aggregation of the historic data can result in different implications:
3 A. Both pre- and post-launch, may only be available as average values aggregated over a long 
4 period, for example if the data access is limited to annual audit figures that cover the entire 
5 pre-launch period.  This scenario implies that no consideration of the disaggregated trends 
6 are possible.  
7 B. Extensive disaggregated data are available both before and after the launch.  This allows for 
8 the direct comparison of each post-launch time-period with some matched period in the 
9 pre-intervention data, for example comparing January in one year with January in the next.  
10 The matching is used to conduct the analysis at a more disaggregated level, as well as 
11 adjusting for other factors such as seasonality and budgetary cycles.  While the average 
12 estimate of the impact of the intervention launch will be the same as part A, we now have 
13 the ability to investigate the change in trend over the time-period. Such a case would occur 
14 either when an evaluation and data collection was started some time before the 
15 intervention launch, or when data on the outcome is readily available retrospectively.  For 
16 example, if the evaluation is concerned with emergency department attendances over time, 
17 historic data can typically be retrospectively collected.  
18
19 Scenario 4 – data are available on a control area post-launch as well as the 
20 intervention area data
21 Scenarios 1-3 describe when data are only available for the area covered by the intervention.  
22 However, data are often available for comparator areas as the informative outcome is often 
23 routinely collected and available across multiple areas, through systems such as Hospital Episode 
24 Statistics (HES), or collection can be prospectively arranged.  Such comparator areas can be local, 
25 regional, national, or a synthetic comparator created by combining a number of areas.  To be an 
26 informative comparator the area must represent a good match to the intervention area in all 
27 relevant characteristics and not be impacted by the launch of the new service being evaluated.[5]  
28 The goodness of the match can be determined qualitatively or quantitatively by comparing the 
29 known features of the two areas. 
30 The most common use of such control data are is to directly compare the post intervention 
31 outcomes in the two areas, using the same approach as scenario 3, but with the contemporary 
32 control data are used instead of the historic intervention area data.  As before, there are two 
33 categories:
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8
1 A. Only aggregate data areData are only available post intervention launch for the two areas.  
2 As in previous scenarios, an example of this would be analyses based on audit data alone but 
3 now across multiple areas. 
4 B. Disaggregated data are available post intervention, allowing  a disaggregated matched 
5 comparison can be made which again, results in the same total estimated impact as part A 
6 but gives us an understanding of the respective trends.  This situation would occur where an 
7 intervention is only launched in one part of a larger geographic area or patient group where 
8 the decision makers has access to the data of the full set prospectively, for example one GP 
9 practice in a CCG area. 
10 Under this scenario, comparator area data are used either instead of, or due to a lack of, historic 
11 evidence as used in scenario 3.  Using simple analytical techniques there is no way to incorporate 
12 both, which we will explore in scenario 6.  There is no hard definitive rule for whether historic or 
13 contemporary comparator evidence is more appropriate, as it is dependent on the situationit is 
14 situation dependent.  For example, if the intervention of interest was not the only change at the 
15 point of launch of the intervention, the control area data would likely be most appropriate if the 
16 second new service was launched in both areas, but not if it were only in the control area.  A number 
17 of other factors must be considered, for example, what if comparator data are available but is not a 
18 good match, how does one define a suitable match, and what if there are multiple comparators 
19 potentially telling different stories?
20
21 Scenario 5 – all pre and post-launch data are available for the intervention 
22 area
23 In this scenario and scenario 6 we explore the addition of more advanced analytical approaches to 
24 the analysis of the data, specifically the use of interrupted time series (ITS) or ‘segmented 
25 regression’ analysis.  This approach has been well presented in the literature,[6-8] but in brief, the 
26 method considers the trend in an outcome of interest over time, segmenting it into the period 
27 before the intervention was launched, and after it.  The example of using pre- and post-launch data 
28 for the intervention area is shown in the explanatory Error! Reference source not found., where the 
29 pre-launch data are used to infer a post-launch counterfactual case, with the nature of the change in 
30 the outcome define a-priori.  Using the framework described by Bernal[8] it is possible to define the 
31 regression model using the equation detailed below, where Y is the aggregated outcome, β 
32 represents the relevant coefficients, T the time since the start of the study, t the specific time-point, 
33 X is a dummy variable indicating when the new intervention is active of the intervention, and ε the 
34 error term.
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9
1
2 𝑌𝑡 =  𝛽0 +  𝛽1𝑇𝑡 +  𝛽2𝑋𝑡 +  𝛽3𝑋𝑡𝑇𝑡 +  𝜀𝑡
3
4 The application of such a regression model allows for the formal estimation of whether any change 
5 in the outcome of interest is statistically significant under a frequentist framework, and for any 
6 change to be quantified by estimating the area between the two regression lines, shown in Error! 
7 Reference source not found., over the analysis period.
8 The use of such method requires time series data both before and after the launch in the 
9 intervention area, as in scenario 3B.
10 [Figure 1 here]
11 Scenario 6 - data are available on both control and intervention areas pre- and 
12 post-launch 
13 We demonstrated in scenario 4 that the addition of control area data typically implied the exclusion 
14 of historic intervention area data in informing the counterfactual.  Using ITS methodology it is 
15 possible to formally incorporate comparator data, potentially from multiple areas or a synthetic 
16 area, alongside the full set of intervention area data.  The method uses the pre-intervention data to 
17 formally test whether the comparator areas can be considered a good match.  If so, the post-launch 
18 comparator data are then used to infer the post-launch counterfactual of the intervention area.  
19 Therefore, this approach assumes that the control area is indicative of what would have happened 
20 to the outcome in the intervention area had the launch not occurred, much as we assumed in 
21 scenario 4 but with a formal assessment of the trend and reliability of the comparator.  The equation 
22 detailed in scenario 5 can be extended by incorporating a Z term as a dummy for assignment to the 
23 treatment or control population, as detailed by Linden[7]:
24
25 𝑌𝑡 =  𝛽0 +  𝛽1𝑇𝑡 +  𝛽2𝑋𝑡 +  𝛽3𝑋𝑡𝑇𝑡 + 𝛽4𝑍 +  𝛽5𝑍𝑇𝑡 +  𝛽6𝑍𝑋𝑡 +  𝛽7𝑍𝑋𝑡𝑇𝑡 +  𝜀𝑡
26
27 Comparing the Scenarios 
28 Each of the scenarios outlined above is characterised by a set of core assumptions, made implicitly 
29 or explicitly, if used to evaluate the impact of a new intervention on some outcome of interest.  
30 Similarly, the variability in the ease of implementation, and data and analytical requirements of each 
31 scenario implies a range of pros and cons associated with each.  These are presented in Table 1, 
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10
1 which highlights that the more analytically simple and data light the scenario the stronger the core 
2 assumption required about the nature of the interaction with the outcome and time trends in the 
3 data.
4
5
6 Table 1: Summary of the different analytical methods
Method Core assumptions Pros Cons
Scenario 1, only data 
after launch in the 
intervention area
Only the change in the data after 
the launch is relevant to the 
evaluation.
Requires little data or technical 
knowledge.
Unable to comment on the 
change in the outcome of 
interest because of the 
intervention, only its trend after 
launch.
Scenario 2A, first and last 
time point of intervention 
period
The two data points are fully 
indicative of the change.
Requires little data or technical 
knowledge.
Highly dependent on small array 
of data.
Risks loss of important details of 
data, intervention effect, or 
trends.
Scenario 2B, 
disaggregated change 
from starting period
Last pre-intervention period fully 
represents the counterfactual.
Only requires one pre-
intervention data point.
Analytically simple. 
Highly dependent on small array 
of control data.
No consideration of trend in 
counterfactual.
Scenario 3A, simple 
average of historic 
intervention area data
Simple averaging of before and 
after data incorporates all 
factors, there is no value in an 
assessment of the trends.
Only requires small amount of 
pre and post data.
Analytically simple.
Fails to explore trends in data. 
Scenario 3B, matched pre 
and post intervention
There is a repeating periodic 
fluctuation, e.g. seasonality, that 
impacts the outcome of interest 
and the trend over time is 
informative.
Simple means of adjusting for 
periodic fluctuations.
Result varies given matching 
approach.
Blunt means of adjusting for 
periodic fluctuations that can 
result in incorrect estimates.
Scenario 4A, comparison 
of averages post 
intervention in control 
and intervention areas
The selected control area fully 
represents the counterfactual of 
the intervention area.
Allows for use of control area 
data.
Only requires post-launch data.
Fails to explore trends in data. 
Makes no use of historic data.
Difficult to determine if the 
control area represents a 
reasonable comparator. 
Scenario 4B, matched 
post intervention control 
and intervention area
The selected control area fully 
represents the counterfactual of 
the intervention area and the 
trend over time is informative.
Allows for use of control area 
data.
Explores trends in data without 
having to define a cycle length.
Only requires post-launch data.
Makes no use of historic data.
Difficult to determine if the 
control area represents a 
reasonable comparator.
Scenario 5, ITS analysis of 
intervention area
Regression of pre-intervention 
data fully represents post-
intervention counterfactual and 
the trend over time is 
informative.
Allows for use of historic control 
data.
Explores the trends.
Reliant on historic intervention 
area data being predictive of 
counterfactual.
Scenario 6, ITS analysis of 
control and intervention 
area
Control area fully represents 
counterfactual of intervention 
area but the match can be tested 
by exploring the pre-intervention 
data. The trend over time is 
informative.
Allows for use of control area 
and exploration as to the 
closeness of the control and 
intervention areas. 
Assumption that the control area 
continues to represent a good 
match after the intervention 
period.
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11
1 Case study
2 To explore the practical implications of the different scenarios, and demonstrate the potential for 
3 varied conclusions, we have created a case study to which each is applied.  To inform the case study 
4 a time series dataset of an outcome unit of interest (e.g. bed days, hospital admissions, or indicators 
5 of quality and care outcome) has been simulated.  The data values and number of time points has 
6 been selected to best inform the characteristics of each of the scenarios described in Table 1 while 
7 representing the uncertain nature of real world data relevant to this setting.  Please see the 
8 supplementary files (“Fabricated data scenarios.xlsm", "Paper analysis.do" and "Fabricated 
9 data.dta“) for additional detail on the data and analyses conducted. 
10 This data relates to two distinct groups (intervention and control) and a maximum of 30 
11 observations are available over some defined time period at regular intervals (e.g. every week, 
12 month, or year).  The data are structured such that in both areas the outcome was increasing for the 
13 first 15 observations at a rate of 4/3 per time period from a mean value of 20 units at time 1, after 
14 which point the intervention is implemented in the intervention area but not the control.  From time 
15 point 15 onwards in the intervention area the outcome decreases at the same rate of 4/3 units per 
16 period, while in the control area the outcome levels off, assumed to be due to factors unrelated to 
17 the intervention.  All time points are subject to some level of variation to mimic what is observed in 
18 real world data, simulated using a normal distribution (mean 45 and standard deviation 5).  We 
19 assume that after launch (t=15) the new service becomes fully operational, with no run in period.  
20 The last time point in the intervention area (t=30) was set as an extreme outlier (estimated as 
21 occurring with a probability of 0.99999 on the simulated distribution) to explore its impact on the 
22 results, for example if an exogenous factor affected the intervention such as failure of a key piece of 
23 machinery.  Error! Reference source not found. shows the fabricated data in full, with each data 
24 point representing the time period before, such that data point 1 being the total outcome over times 
25 0 to 1.  
26  [Figure 2 here]
27 Using the informative structure of the simulated case study it is possible to estimate two possible 
28 underlying effect values.  If the control area is the best indicator of the counterfactual the 
29 intervention resulted in a reduction of 151 units over the period, if the historic intervention area is 
30 best, a reduction of 324 units.  While these values can help us to understand the results of the 
31 different scenarios they must be interpreted with caution;, as while they inform the underlying trend 
32 used to simulate the data the case study time points were sampled independently. 
33 In the next part we explore what the data availability would look like under each of the scenarios 
34 outlined in the previous section, estimating what the impact and conclusions would be regarding the 
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12
1 effectiveness of the intervention.  As outlined earlier, in many of the cases only a limited set of the 
2 data are available, indeed it is only scenarios 4 and 6 where the full dataset is available to the 
3 decision maker.  Error! Reference source not found. provides an overview of the data availability 
4 across all of the scenarios.
5
6 [Figure 3 here]
7
8
9
10
11
12
13 Table 2 gives an overview of the results of the different possible scenarios and possible 
14 interpretations.  
15 Table 2: Summary of the different scenarios results
Scenario Possible interpretation of the result Estimated change1 
Scenario 1, only data after 
launch in the intervention 
area
The outcome of interest appears to have decreased over 
the post-launch time-period
not possible to 
estimate a change in 
the outcome
Scenario 2A, first and last time 
point of intervention period
There appears to have been an increase in the outcome 
from the pre-launch to post-launch period.  
Extrapolating the observed values over the entire 15 
months of intervention suggests that the new 
intervention had increased the outcome by 37.6 units 
((44.9-42.4)x15)
37.6
Scenario 2B, disaggregated 
change from starting period
The outcome of interest appears to have decreased over 
time from the pre-launch time-period, with an estimated 
change of -120.1 units over the period ((34.4-42.4)x15)
-120.1
Scenario 3A, simple average of 
historic intervention area data
There appears to have been little change from the pre- 
to post-launch periods in the outcome, with the average 
value going from 35.1 to 35.4
((35.4-35.1)x15)
4.9
Scenario 3B, matched pre and 
post intervention
There appears to have been little change from the pre- 
to post-launch periods in the outcome, with the average 
value going from 35.1 to 35.4. However, it appears from 
the data that there was an increasing trend in the 
outcome before the intervention and a decreasing trend 
afterwards
((35.4-35.1)x15)
4.9
Scenario 4A, comparison of 
averages post intervention in 
control and intervention areas
Compared to the control area the intervention area had 
a lower average level of the outcome after the launch of 
the intervention
-146.0
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13
Scenario 4B, matched  post 
intervention control and 
intervention area
Compared to the control area the intervention area had 
a lower average level of the outcome after the launch of 
the intervention.  The control area appeared to have a 
flat trend in the outcome over the post-launch period 
compared to a decreasing trend in the intervention area
((35.4-45.1)x15)
-146.0
Scenario 5, ITS analysis of 
intervention area
Compared to the pre-launch intervention area the post-
launch saw a decrease in the trend over time in the 
outcome, from positive to negative, which was 
statistically significant
See the Supplementary Appendix for regression
-258.8
Scenario 6, ITS analysis of 
control and intervention area
Both control and intervention areas saw a shallowing of 
the trend over time.  The intervention area saw a greater 
decrease in the trend, being negative compared to the 
relatively flat trend in the control.  This different was 
statistically significant. The control area was found to be 
a match to the intervention area in the pre-launch 
period (the regressions lines are aligned), 
See the Supplementary Appendix for regression
-146.0
1 1negative values indicate that the new service reduced the outcome
2 Error! Reference source not found. and Table 2 demonstrate the large potential for variation in the 
3 estimated impact of the intervention, and the overall conclusions that could be drawn given the 
4 different scenarios.  Estimations of the change in the outcome vary from predicting the intervention 
5 increased the outcome by 37.6 units over the post-intervention period (scenario 2A), to decreasing it 
6 by 258.8 (scenario 5).  Similarly the interpretations differ in their ability to identify the trends in the 
7 different areas and time periods, as well as the overall impact of the intervention.  
8 In the case study presented here, with full access to the data and knowledge of the underlying 
9 trends in the simulated data, it is clear that several of these scenarios result is a very incorrect 
10 conclusion.  However, the appropriateness of the scenarios and accuracy of their conclusions 
11 compared to any ‘true’ effects are clearly much harder to determine in the real world.
12
13 Discussion
14 In this paper we have explored a range of possible scenarios and analytical approaches available to a 
15 decision maker when evaluating the impact of a new intervention on an outcome of interest, 
16 highlighting the implicit assumptions made in each.  Through our simulated case study we have 
17 demonstrated how these scenarios can yield very different estimates of effectiveness.  
18 Comparison of the methods explored here suggests that it is intuitively appealing to conclude that 
19 the approach outlined in scenario 6, using the ITS methodology including the control area 
20 comparison, is the most accurate as it incorporates the most complete set of data whilst taking the 
21 most complete approach to statistical analysis.  However, the most appropriate methodology may 
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1 be driven by other factors, primarily the availability of informative data and the validity of the core 
2 assumptions detailed in Table 1. 
3 Furthermore, the use of ITS analysis (scenarios 5 and 6) is not without assumptions, primarily 
4 relating to the suitability of the historic and control area data to inform the counterfactual, and the 
5 functional form of the trends modelled.  It also requires a significant level of data and analytical 
6 ability to implement.  However, the inability to observe exactly what would happen in the 
7 intervention area without the new service, necessitates such assumptions in order to estimate the 
8 impact of its launch.  Fears about the robustness of such assumptions are likely to be best addressed 
9 by the identification of additional relevant evidence to either adjust the existing data or inform a 
10 new comparator.  For example, methods are available to overcome concerns over additional service 
11 changes in the time period covered by the data,[7] to incorporate multiple control areas,[7] and to 
12 conduct a more rigorous selection of control area through matching.[9]
13 As with all such analyses, the ITS methodology can be extended to consider the significance of the 
14 findings beyond pure chance.  This can be achieved through a frequentist framework, considering 
15 the statistical significance of the regression estimates, as discussed in Linden et al.,[7] or through a 
16 Bayesian framework.[10]  Such considerations should play an important role in the decision making 
17 process, as a single estimate of the impact on an intervention can be misleading. Specifically, it fails 
18 to take account of the uncertainty, of the informative data or the consequences of making an 
19 incorrect funding decision.  However, it is important to reflect that even if there is substantial 
20 uncertainty it is the mean expected estimate of the impact of the intervention that should be most 
21 informative to the commissioning decision, rather than the significance of the impact, as argued by 
22 Claxton [11]. 
23 An intrinsic element to any analyses explored in this paper is an understanding of the data under 
24 interrogation,: the application of robust methods is only helpful if the data being used is consistent 
25 and relevant to the question being addressedit is being used to answer.  Prior to any analysis it is 
26 important to understand the data, answering questions such as: how was it generated;, is an 
27 estimate of the rate of an event more relevant than it’s frequency,; is it consistent over the time 
28 period of interest,; what is the route of causality between the intervention of interest and the data;, 
29 and when plotted do there appear to be any unexplainable outliers? 
30 Analyses such as those presented here are most robust when combined with qualitative 
31 methodologies through a mixed-method approach, with the qualitative findings ideally facilitating a 
32 more detailed understanding of the trends seen in the data and informing the suitability of the 
33 different counterfactual scenarios.  Such a mixed-methods approach may extend the quantitative 
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1 incorporate health economic considerations, such that the generalisable cost-effectiveness of the 
2 intervention is considered. 
3 Furthermore, the use of robust methodologies, such as ITS analysis, does not replace the need for 
4 the robust identification selection of relevant outcomes and data collection, alongside the 
5 prospective planning of evaluations,, as any analysis can only be as robust as the data that informs it.  
6 Therefore, fFailure to prospectively design the launch of an intervention launch and associated 
7 evaluation which to ensure  ensures the robust implementation of the new intervention, the 
8 required level of data collection, and sufficient consideration ofas to a contemporaneous control, 
9 will likely lead to an erroneous result whatever evaluative method is used.  
10
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1 Figure legends and captions
2 Figure 1: ITS analytical method
3 Figure 2: Fabricated time series data
4 Figure 3: Data availability across the different scenarios of the case study
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